Credo Diagnostics is pleased to announce our participation at the coming 32nd ECCMID event from April 23 – 26, 2022.
ECCMID is recognized as the world’s premier Clinical Microbiology & Infectious Diseases event and brings together experts from many fields to present their latest findings, guidelines, and experiences to an audience of 14,000 visitors. This year, the congress will feature a hybrid format to facilitate an onsite and online experience for attendees, allowing for remote and face-to-face opportunities to take part in the multifaceted program.
Credo Diagnostics will showcase the VitaPCR™ instrument, our true Point-of-Care and accurate molecular diagnostic solution based on the real-time Polymerase Chain Reaction (real-time PCR) technology. At the event, we will be providing live hands-on testing and also demonstrate how VitaDataLink, our connectivity software, solves data management issues.
We invite all visitors
to come and learn why our COVID-19 solution is now used in many parts of the world – from mobile drive through testing stations, to major airports, cruise ships, laboratories, oil drilling platforms and even onboard the frigates of a major European Navy fleet
to visit us and find out why our solution is easily associated by many users as the solution for quick and accurate point-of-care molecular tests
We look forward to receiving all visitors to our Booth No.2-19.2.
Asian Flush and Easily Drunk: The Genetics of Alcohol Intolerance
Can you handle your liquor effortlessly, or do you turn bright red after just one drink? Either way, it’s not unusual—alcohol metabolism varies from person